Alpha 2.0
Login Register
» Articles » PMID: 689741

Cyclophosphamide Effects on Murine Cryptococcosis

Overview
Journal Infect Immun
Publisher American Society for Microbiology
Specialty Allergy & Immunology
Date 1978 Aug 1
PMID 689741
Citations 11
Authors
J R Graybill
L Mitchell
Affiliations
Soon will be listed here.
Abstract

BALB/c mice were given cyclophosphamide and challenged with Cryptococcus neoformans. Delayed-type hypersensitivity was transiently depressed, and survival was either unaffected or shortened by cyclophosphamide.

Citing Articles

Mouse models for the study of fungal pneumonia: a collection of detailed experimental protocols for the study of Coccidioides, Cryptococcus, Fusarium, Histoplasma and combined infection due to Aspergillus-Rhizopus.

Muhammed M, Feldmesser M, Shubitz L, Lionakis M, Sil A, Wang Y Virulence. 2012; 3(3):329-38.

PMID: 22546902 PMC: 3442846. DOI: 10.4161/viru.20142.

Involvement of C3a and C5a in interleukin-8 secretion by human polymorphonuclear cells in response to capsular material of Cryptococcus neoformans.

Vecchiarelli A, Retini C, Casadevall A, Monari C, Pietrella D, Kozel T Infect Immun. 1998; 66(9):4324-30.

PMID: 9712784 PMC: 108522. DOI: 10.1128/IAI.66.9.4324-4330.1998.

Mechanisms of protective immunogenicity of microbial vaccines: effects of cyclophosphamide pretreatment in Venezuelan encephalitis, Q fever and tularaemia.

Ascher M, Jahrling P, Harrington D, Kishimoto R, MCGANN V Clin Exp Immunol. 1980; 41(2):225-36.

PMID: 7438552 PMC: 1536999.

Immunization of mice by intracutaneous inoculation with viable virulent Cryptococcus neoformans: immunological and histopathological parameters.

Moser S, LYON F, Domer J, Williams J Infect Immun. 1982; 35(2):685-96.

PMID: 7035372 PMC: 351096. DOI: 10.1128/iai.35.2.685-696.1982.

Natural cell-mediated cytotoxicity against Candida albicans induced by cyclophosphamide: nature of the in vitro cytotoxic effector.

Baccarini M, Bistoni F, Puccetti P, Garaci E Infect Immun. 1983; 42(1):1-9.

PMID: 6352489 PMC: 264515. DOI: 10.1128/iai.42.1.1-9.1983.

References
1.
Graybill J, Taylor R . Host defense in cryptococcosis. I. An in vivo model for evaluating immune response. Int Arch Allergy Appl Immunol. 1978; 57(2):101-13. View
2.
Kerckhaert J, Hofhuis F, Willers J . Influence of cyclophosphamide on delayed hypersensitivity and acquired cellular resistance to Listeria monocytogenes in the mouse. Immunology. 1977; 32(6):1027-32. PMC: 1445441. View
3.
Finerty J, Krehl E . Cyclophosphamide pretreatment and protection against malaria. Infect Immun. 1976; 14(4):1103-5. PMC: 415498. DOI: 10.1128/iai.14.4.1103-1105.1976. View
4.
Sher N, Chaparas S, Greenberg L, Bernard S . Effects of BCG, Corynebacterium parvum, and methanol-extration residue in the reduction of mortality from Staphylococcus aureus and Candida albicans infections in immunosuppressed mice. Infect Immun. 1975; 12(6):1325-30. PMC: 415439. DOI: 10.1128/iai.12.6.1325-1330.1975. View
5.
DIAMOND R, May J, Kane M, Frank M, Bennett J . The role of the classical and alternate complement pathways in host defenses against Cryptococcus neoformans infection. J Immunol. 1974; 112(6):2260-70. View